UBS initiates Shiseido stock coverage with Neutral rating amid restructuring

UBS initiated coverage on Shiseido Co Ltd. (4911:JP) with a Neutral rating and a JPY2,650.00 price target, citing positive restructuring efforts but expressing concerns over limited top-line growth prospects in key markets like China, travel retail, and Japan, alongside underperformance from its Drunk Elephant brand. Despite these headwinds, the bank noted that the stock's current valuation of 9x EV/EBITDA for 2026, after a 40% share price correction, indicates most negative factors are already reflected in the price.

Analysis

UBS has initiated coverage on Shiseido Co Ltd. (4911:JP) with a Neutral rating and a JPY 2,650 price target, reflecting a balanced but cautious outlook. The bank acknowledges that the company's restructuring initiatives are yielding positive results for profitability. However, significant concerns remain regarding top-line growth, with UBS highlighting limited revenue upside in Shiseido's most profitable segments: China and travel retail. This is compounded by slowing sales in its home market of Japan and the disappointing performance of the Drunk Elephant brand, which is negatively impacting results in the EMEA and Americas regions. The bank also expressed reservations about the company's 7% core operating profit margin guidance for 2026. From a valuation standpoint, UBS notes that after a 40% share price correction since 2024, the stock trades at 9 times its 2026 estimated EV/EBITDA. This multiple is in line with local peers and 1.5 standard deviations below its own historical average, suggesting that the prevailing market headwinds are largely reflected in the current stock price.

Key Decisions for Investors

• Given the stock's 40% price correction and valuation in line with peers, investors should recognize that substantial negative news is likely already priced in, potentially limiting further downside risk on current information.
• Investors looking for near-term growth should remain cautious, as the report flags specific headwinds including limited upside in the high-margin China and travel retail channels and underperformance of the Drunk Elephant brand.
• It is prudent to monitor for a turnaround in the Drunk Elephant brand's sales and any signs of re-acceleration in the China or travel retail segments, as these would be key catalysts for a potential re-rating of the stock.
• Consider the current Neutral rating as indicative of a hold position, as the positive impact from restructuring appears offset by a challenging revenue growth outlook, creating a lack of clear short-term catalysts for significant outperformance.